BC
Binny Chopra
About Binny Chopra
Binny Chopra has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Zalix Pharmaceuticals Private Limited and Awake Life Sciences Llp. Formerly with 2 companies, such as Zymes Bioscience Private Limited and Lymnox Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Zalix Pharmaceuticals Private Limited
U74993DL2018PTC333678
|
Director | 24 May 2021 | 2018 | Active |
Awake Life Sciences Llp
AAD-5626
|
Designated Partner | 18 Mar 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Zymes Bioscience Private Limited
U51102DL2012PTC234105
|
Director | 22 May 2021 | 2012 | Active |
Lymnox Life Sciences Private Limited
U74999DL2018PTC335624
|
Director | 21 Jun 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Binny Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Binny Chopra
Binny Chopra has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Zalix Pharmaceuticals Private Limited and Awake Life Sciences Llp. Formerly with 2 companies, such as Zymes Bioscience Private Limited and Lymnox Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Binny Chopra is associated with 2 companies as Director and Designated Partner.
Binny Chopra has expertise in General Business.
Binny Chopra has 11 years in corporate governance.